Pre-natal and Post-natal Screening and Testing in Neonatal Abstinence Syndrome
Ostfeld-Johns S. Pre-natal and Post-natal Screening and Testing in Neonatal Abstinence Syndrome. Seminars In Perinatology 2024, 152009. PMID: 39603974, DOI: 10.1016/j.semperi.2024.152009.Peer-Reviewed Original ResearchSubstance useSubstance use disorder diagnosisEvidence of clinical utilityDecrease stigmaDelivery hospitalizationsBirthing personsHealthcare providersIncreased stigmaCompassionate communicationPrenatal visitHealthcare systemNeonatal abstinence syndromePromote engagementPotential withdrawal symptomsPost-natal screeningRisk of withdrawalToxicology testingDisorder diagnosisAbstinence syndromeHealthcareStigmaWithdrawal symptomsFamily environmentClinical utilityNewbornsA Comparison of Two Statewide Datasets to Understand Population Prevalence of Substance Use in Pregnancy: Findings and Considerations for Policy & Research
Sieger M, Morin J, Budris L, Sienna M, Ostfeld-Johns S, Hart L, Morosky C. A Comparison of Two Statewide Datasets to Understand Population Prevalence of Substance Use in Pregnancy: Findings and Considerations for Policy & Research. Maternal And Child Health Journal 2024, 28: 1121-1131. PMID: 38539033, PMCID: PMC11060901, DOI: 10.1007/s10995-024-03914-6.Peer-Reviewed Original ResearchConceptsSubstance use disordersSubstance useBlack mothersPregnancy-related deathsFederal Child Abuse PreventionMental health conditionsPublic health aimSelf-reported drug useMaternal self-reportDrug usePrevalence of substance useChild protective services involvementProtective services involvementMothers self-reportedChild abuse preventionSelf-reported dataStatistically similar ratesPrenatal substance exposureSelf-report ratingsHealth aimRate of whitesHispanic mothersHealth conditionsHospital personnelSelf-report